Dr. Irina Budunova obtained her MD degree from Pirogov State Medical University, and Ph.D. degree from National Cancer Center (Moscow, Russia). In 1992 she moved to USA, and worked at M.D. Anderson Cancer Center (Smithville, TX, USA), at AMC Cancer Research Center (Denver, CO, USA), and at the Department of Dermatology at Northwestern University (Chicago, IL, USA). Currently she is a Professor at Northwestern University. The major focus of Dr. Budunova’s research is the Glucocorticoid Receptor (GR) signaling in skin. She was actively involved in the development of alternative GR ligands, and GR-targeted therapies to improve glucocorticoid therapeutic index, and decrease their catabolic affects.
Title : PI3-Kinase inhibitors represent a novel class of drug repurposing candidates to prevent/ alleviate glucocorticoid-induced skin atrophy